New study tests apremilast to tame psoriasis Flare-Ups
NCT ID NCT07190391
First seen Sep 30, 2025 · Last updated May 25, 2026 · Updated 36 times
Summary
This study tests the drug apremilast in 425 adults with moderate-to-severe psoriasis that has lasted at least 6 months. The main goal is to see how many people achieve at least a 75% improvement in skin symptoms after 16 weeks. The study is open-label, meaning everyone knows they are getting the drug, and it lasts 32 weeks to check both effectiveness and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.